Search

everythinglearnresearchcommunity

for

Search:↓

CTLA4 gene variants are not linked to alopecia areata in Monterrey's Mexican population.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

A woman with Kallman's syndrome also developed alopecia universalis, a condition not previously linked to Kallman's.

Certain gene variations increase the risk of alopecia areata in Koreans.

Personalized treatment plans are important for people with alopecia areata.

Early recognition and treatment of atypical alopecia areata in infants are crucial.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Herbal medications might be safer and more effective for hair loss than synthetic treatments.

Older men's scalp damage increases with age and sun exposure, a baby girl in the Philippines has Schimmelpenning syndrome, and thyroid screening is advised for children with hair loss and certain risk factors.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

Finasteride treats hair loss and reduces prostate cancer risk.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

White hairs often regrow in alopecia areata patches.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Women with thyroid disease are more likely to experience female pattern hair loss, especially if they've had thyroid disease for a long time.

Lactoferrin levels are lower in people with chronic hair shedding, suggesting supplements could help treat it.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata in infants may be more common than previously thought.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.